plerixafor
Showing 1 - 25 of 76
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
- Plerixafor
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023
Sickle Cell Disease Trial in Memphis (Plerixafor)
Recruiting
- Sickle Cell Disease
- Plerixafor
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 11, 2023
Sickle Cell Disease Trial in Boston, Memphis (MGTA-145, Plerixafor)
Recruiting
- Sickle Cell Disease
- MGTA-145
- Plerixafor
-
Bethesda, Maryland
- +2 more
Nov 4, 2022
Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)
Completed
- Multiple Myeloma
- MGTA-145
- Plerixafor
-
Stanford, CaliforniaStanford University
Aug 17, 2022
Sickle Cell Disease Trial in Duarte (Plerixafor)
Recruiting
- Sickle Cell Disease
- Plerixafor
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Sickle Cell Disease Trial in New York (Plerixafor)
Recruiting
- Sickle Cell Disease
- Plerixafor
-
New York, New York
- +1 more
Mar 21, 2022
Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- Idiopathic CD4-Positive
- T-Lymphocytopenia
- Filgrastim
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure Trial in Orange (Plerixafor)
Not yet recruiting
- Asherman Syndrome
- +2 more
- Plerixafor
-
Orange, ConnecticutYale Fertility Center
Jul 13, 2022
Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)
Recruiting
- Sickle Cell Anemia
- Beta Thalassemia
- TBI
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)
Not yet recruiting
- HIV
- Hematologic Malignancies
- RIC
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients
Active, not recruiting
- Multiple Myeloma
- Plerixafor
-
Torino, ItalyA.O.U. Città della Salute e della Scienza di Torino
Aug 17, 2021
Sickle Cell Disease Trial in United States (biological, drug, genetic)
Recruiting
- Sickle Cell Disease
- Plerixafor
- +2 more
-
Oakland, California
- +5 more
Sep 13, 2022
Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)
Completed
- Stem Cell Transplantation
- Leukemia
- Plerixafor
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 22, 2020
Transplants and Implants Trial in Cincinnati (plerixafor, Bortezomib, plasmapheresis)
Unknown status
- Transplants and Implants
- plerixafor
- +2 more
-
Cincinnati, Ohio
- +1 more
Jun 29, 2020
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
- Plerixafor
-
Tampa, Florida
- +11 more
Sep 3, 2020
Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford
Recruiting
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- +5 more
- Purified regulatory T-cells (Treg) plus CD34+ HSPC
- +7 more
-
Stanford, CaliforniaStanford University
Oct 28, 2021
Multiple Myeloma Trial in United States (Plerixafor, bortezomib, Dexamethasone)
Completed
- Multiple Myeloma
- Plerixafor
- +2 more
-
Boston, Massachusetts
- +4 more
May 19, 2020
Sickle Cell Disease Trial run by the NHLBI (Plerixafor)
Completed
- Sickle Cell Disease
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 13, 2020
Pancreas Cancer Trial in New York, Cambridge (Plerixafor)
Terminated
- Pancreas Cancer
- Plerixafor
-
New York, New York
- +1 more
Feb 27, 2020
Diabetes, Wounds, Critical Limb Ischemia Trial in Padova (Plerixafor, Placebo)
Terminated
- Diabetes
- +2 more
- Plerixafor
- Placebo
-
Padova, ItalyUniversity Hospital of Padova
Dec 17, 2019